Literature DB >> 30387603

Achieving NIR Emission for Donor-Acceptor Type Platinum(II) Complexes by Adjusting Coordination Position with Isomeric Ligands.

Youming Zhang1,2, Zhao Chen2, Xin Wang1, Junjie He1, Jiatao Wu1,2, Haiyang Liu1,2, Jun Song1, Junle Qu1, Wesley Ting-Kwok Chan2, Wai-Yeung Wong2.   

Abstract

Four platinum(II) complexes Pt-1, Pt-2, Pt-3, and Pt-4 with the isomeric donor-acceptor (D-A) conjugated ligand framework are designed and prepared, and their thermal, photophysical, and electrochemical characteristics investigated. Crystal structures for Pt-1 and Pt-4 are determined with single-crystal X-ray diffraction analysis, showing distorted and nonplanar geometry. Complex Pt-4 exhibits much greater distortion, attributed to the steric interactions between benzothiadiazole and naphthalene. Remarkably different photophysical, electrochemical, and electroluminescent properties are found for these platinum(II) complexes. Photoluminescence wavelengths of these complexes range from 590 to 800 nm with bandgaps of 1.7-2.0 eV. Coordination with [1,2,5]thiadiazolo[3,4- c]pyridine and triphenylamine can enhance D-A interactions, reducing the bandgap and producing near-infrared emission for Pt-3. Organic light-emitting devices (OLEDs) display electroluminescence with emission peaks at 626, 645, 826, and 571 nm, with maximum external quantum efficiencies of 0.13%, 0.04%, 0.49%, and 0.22% for Pt-1, Pt-2, Pt-3, and Pt-4 doped OLEDs, respectively. Thus, adjusting the coordination position with the isomeric conjugation framework ligand is an appropriate strategy to tune the light-emitting properties of platinum complexes in OLEDs.

Entities:  

Year:  2018        PMID: 30387603     DOI: 10.1021/acs.inorgchem.8b02220

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  Heteroleptic Zn(II) Complexes: Synthesis, Characterization and Photoluminescence Properties.

Authors:  Jaydip Solanki; Kiran Surati
Journal:  J Fluoresc       Date:  2019-07-20       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.